Early Access — free while we kick the tires
EdgarHawk

Frisch Scott M.

Director

Director
3 filings analyzed · 1 company · Latest 2024-09-10

Companies

Company Buys Sells Direction
Carmell Corp XAGE 4 0 Net buying

Activity

September 2024
2024-09-10 Carmell Corp XAGE
low
Buy
1,009 shares
$515
Significance 3/10

Director Frisch buys 1,009 shares at $0.51; stock down -90.4% from 52-week high, $9.8M market cap, unprofitable fundamentals.

Frisch Scott M. purchased 1,009 shares at $0.51 on 2024-09-06, raising his holdings to 7,598 shares (+15.3% increase). The timing context is highly unfavorable: CTCX has declined -55.2% in the 30 days prior and -77.5% over 90 days, now trading -90.4% below its 52-week high of $4.87. At the same-ticker level, his two prior measurable purchases in December 2023 each posted negative 90-day returns (-10.6% and -2.6%), indicating his prior buys at this stock were not well-timed. Fundamentally, the company reported $12.3K revenue in the latest quarter with a -$3.3M net loss and an overall unprofitable year, yet the stock is still valued at $9.8M market cap. The buy occurs within a cluster pattern: 5 other insiders also purchased within the past 14 days, which at minimum establishes coordinated or synchronized activity rather than an isolated conviction signal.

2024-09-04 Carmell Corp XAGE
medium
Buy
87 shares
$50
Significance 4/10

Director Scott M. Frisch bought 87 CTCX shares at $0.57; stock down -88.5% from 52-week high amid -$3.3M net loss and cluster buying.

Director Frisch Scott M. purchased 87 shares at $0.57 on 2024-08-30, increasing his holdings to 6,589 shares (+1.3% vs. pre-transaction). The transaction occurred as Carmell Corp (CTCX) trades at $0.56 current price, down -88.5% from its 52-week high of $4.87, with the stock declining -50.0% over the past 30 days and -78.4% over 90 days. The company's fundamentals are deteriorating: revenue stands at $12.3K in the latest quarter against a net loss of -$3.3M, with the company unprofitable over its most recent full fiscal year. Notably, this purchase is part of a cluster pattern with 5 other insiders also buying within the past 14 days. However, Frisch's prior trades at this ticker show poor timing outcomes: his 3 measurable prior buys at CTCX (in December 2023) all resulted in negative 90-day returns (-10.6%, -2.6%, -36.8%), with 0 of 3 well-timed at the 90-day mark.

August 2024
2024-08-30 Carmell Corp XAGE
medium
Buy
1,121 shares
$628
Significance 4/10

Director Frisch Scott M. purchased 1,121 shares at $0.56 in 2 transactions, raising holdings 20.8%; stock down 86.9% from 52-week high amid cluster buying.

Director Frisch Scott M. executed 2 separate purchases totaling 1,121 shares for $627.76 at $0.56 on consecutive days (2024-08-28 and 2024-08-29), increasing his holdings to 6,502 shares. This 20.8% increase in position size occurs against a backdrop of severe price deterioration: the stock has fallen 39.6% in the last 30 days and 74.3% in the last 90 days, currently trading at $0.64 versus a 52-week high of $4.87. At CTCX specifically, Frisch's prior 4 measurable trades from December 2023 all underperformed materially at the 90-day mark, with a 0% timing success rate. The company is unprofitable with net income of $-3,304,538.00 against revenue of $12,320.00, and 6 other insiders have also bought within the past 14 days. The accumulation occurs amid fundamental weakness and a clear pattern of the director's prior purchases at this ticker not capturing value within the subsequent three-month window.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access